Trial Profile
Study of improvement effect by switching to duraglutide or addition of empagliflozin to patients mith poor blood glucose control under multidrug combination including dipeptidyl peptidase-4inhibitor(Randomized openlabel comparative clinical study)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Jun 2017 New trial record